Organism name | Lippia dulcis TREV. |
---|---|
Genus | Lippia |
Family | Verbenaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Lippia |
---|---|
Linked NCBI taxonomy ID | 320344 |
Linked level | genus |
Family in NCBI taxonomy | Verbenaceae |
---|---|
ID | 21910 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | asterids |
---|---|
ID | 71274 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00003894
![]() |
Eupatorin
/ 3',5-Dihydroxy-4',6,7-trimethoxyflavone / 5-Hydroxy-2-(3-hydroxy-4-methoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL487402
|
C103110
|
5 / 5 / 4 | 5 / 0 | No. 3 | No. 15 |
![]() |
C00003837
![]() |
Cirsimaritin
|
CHEMBL348436
|
C007072
|
13 / 18 / 14 | No. 3 | No. 15 |
![]() |
|
C00003947
![]() |
5,3'-Dihydroxy-6,7,4',5'-tetramethoxyflavone
/ 5-Hydroxy-2-(3-hydroxy-4,5-dimethoxyphenyl)-6,7-dimethoxy-4H-1-benzopyran-4-one |
No. 8 | No. 15 |
![]() |
||||
C00003898
![]() |
5-Hydroxy-6,7,3',4'-tetramethoxyflavone
/ 6-Hydroxyluteolin 6,7,3',4'-tetramethyl ether / 2-(3,4-Dimethoxyphenyl)-5-hydroxy-6,7-dimethoxy-4H-1-benzopyran-4-one |
CHEMBL226508
|
C045324
|
No. 8 | No. 15 |
![]() |
||
C00002783
![]() |
Kusaginin
/ Acteoside / Verbascoside |
CHEMBL231853
CHEMBL444478 CHEMBL1364101 |
C058956
|
12 / 1 / 1 | 34 / 3 | No. 33 |
![]() |
|
C00030516
![]() |
Isoacteoside
/ Isoverbascoside |
CHEMBL504873
|
C064683
|
6 / 5 / 4 | No. 33 |
![]() |
||
C00003840
![]() |
Salvigenin
|
CHEMBL376644
|
C014049
|
No. 35 | No. 15 |
![]() |
||
C00010590
![]() |
Lamiide
|
No. 56 | No. 36 |
![]() |
||||
C00035981
![]() |
8-Epiloganin
|
CHEMBL1081584
CHEMBL1081586 CHEMBL1589904 CHEMBL2135791 |
2 / 1 / 1 | No. 56 | No. 36 |
![]() |
||
C00030098
![]() |
Verbasoside
/ (-)-Verbasoside / Decaffeoylverbascoside / (-)-Decaffeoylverbascoside |
CHEMBL1779146
|
No. 128 | No. 72 |
![]() |
|||
C00031768
![]() |
Epilippidulcine A
/ (-)-Epilippidulcine A |
No. 3312 |
![]() |
|||||
C00031981
![]() |
Lippidulcine A
|
No. 3312 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00002783 C00003837 | 0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | C00002783 C00003837 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00002783 C00035981 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00003837 | 7 / 3 |
P06746 | DNA polymerase beta | Enzyme | C00003837 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00003837 | 6 / 4 |
P17252 | Protein kinase C alpha type | Alpha | C00002783 | 0 / 0 |
P39900 | Macrophage metalloelastase | M10A | C00030516 | 0 / 0 |
P14780 | Matrix metalloproteinase-9 | M10A | C00030516 | 2 / 2 |
O14965 | Aurora kinase A | Aur | C00003894 | 0 / 0 |
P04798 | Cytochrome P450 1A1 | Cytochrome P450 1A1 | C00003894 | 0 / 0 |
P60033 | CD81 antigen | Unclassified protein | C00035981 | 1 / 1 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00003837 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00002783 | 0 / 0 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00003837 | 0 / 3 |
P43220 | Glucagon-like peptide 1 receptor | Glucagon-like peptide receptor | C00003837 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00030516 | 0 / 1 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00003837 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00003837 | 1 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00002783 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002783 | 0 / 0 |
Q16678 | Cytochrome P450 1B1 | Cytochrome P450 1B1 | C00003894 | 4 / 4 |
Q96GD4 | Aurora kinase B | Aur | C00003894 | 0 / 0 |
P35968 | Vascular endothelial growth factor receptor 2 | Vegfr | C00003894 | 1 / 0 |
P45452 | Collagenase 3 | M10A | C00030516 | 1 / 1 |
P08253 | 72 kDa type IV collagenase | M10A | C00030516 | 1 / 3 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00003837 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00002783 | 1 / 1 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00002783 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00003837 | 4 / 3 |
P08254 | Stromelysin-1 | M10A | C00030516 | 1 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00002783 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00003837 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002783 | 0 / 0 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00002783 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00002783
C00003894
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00002783
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00002783
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00002783
|
894 | CCND2, KIAK0002 | cyclin D2 |
C00002783
|
896 | CCND3 | cyclin D3 |
C00002783
|
898 | CCNE1, CCNE | cyclin E1 |
C00002783
|
1017 | CDK2, p33(CDK2) | cyclin-dependent kinase 2 (EC:2.7.11.22) |
C00002783
|
1019 | CDK4, CMM3, PSK-J3 | cyclin-dependent kinase 4 (EC:2.7.11.22) |
C00002783
|
1021 | CDK6, PLSTIRE | cyclin-dependent kinase 6 (EC:2.7.11.22) |
C00002783
|
1026 | CDKN1A, CAP20, CDKN1, CIP1, MDA-6, P21, SDI1, WAF1, p21CIP1 | cyclin-dependent kinase inhibitor 1A (p21, Cip1) |
C00002783
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00002783
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00002783
|
196 | AHR, bHLHe76 | aryl hydrocarbon receptor |
C00002783
|
1869 | E2F1, E2F-1, RBAP1, RBBP3, RBP3 | E2F transcription factor 1 |
C00002783
|
1956 | EGFR, ERBB, ERBB1, HER1, PIG61, mENA | epidermal growth factor receptor (EC:2.7.10.1) |
C00002783
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00002783
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00002783
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00002783
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00002783
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00002783
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00002783
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00002783
|
27035 | NOX1, GP91-2, MOX1, NOH-1, NOH1 | NADPH oxidase 1 |
C00002783
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00002783
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00002783
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00002783
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00002783
|
4088 | SMAD3, HSPC193, HsT17436, JV15-2, LDS1C, LDS3, MADH3 | SMAD family member 3 |
C00002783
|
6648 | SOD2, IPOB, MNSOD, MVCD6 | superoxide dismutase 2, mitochondrial (EC:1.15.1.1) |
C00002783
|
7039 | TGFA, TFGA | transforming growth factor, alpha |
C00002783
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00002783
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00002783
|
7412 | VCAM1, CD106, INCAM-100 | vascular cell adhesion molecule 1 |
C00002783
|
1545 | CYP1B1, CP1B, CYPIB1, GLC3A, P4501B1 | cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) |
C00003894
|
1557 | CYP2C19, CPCJ, CYP2C, P450C2C, P450IIC19 | cytochrome P450, family 2, subfamily C, polypeptide 19 (EC:1.14.13.48 1.14.13.49 1.14.13.80) |
C00003894
|
1565 | CYP2D6, CPD6, CYP2D, CYP2D7AP, CYP2D7BP, CYP2D7P2, CYP2D8P2, CYP2DL1, CYPIID6, P450-DB1, P450C2D, P450DB1 | cytochrome P450, family 2, subfamily D, polypeptide 6 (EC:1.14.14.1) |
C00003894
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00003894
|
OMIM | preferred title | UniProt |
---|---|---|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#137750 | Glaucoma 1, open angle, a; glc1a |
Q16678
|
#231300 | Glaucoma 3, primary congenital, a; glc3a |
Q16678
|
#137760 | Glaucoma, primary open angle; poag |
Q16678
|
#602089 | Hemangioma, capillary infantile |
P35968
|
#613496 | Immunodeficiency, common variable, 6; cvid6 |
P60033
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#604229 | Peters anomaly |
Q16678
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#602111 | Spondyloepimetaphyseal dysplasia, missouri type |
P45452
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | name | UniProt |
---|---|---|
H00028 | Choriocarcinoma |
P03956
(related)
P08253 (related) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00025 | Penile cancer |
P08253
(related)
P14780 (related) P35354 (related) |
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
P45452 (related) |
H00017 | Esophageal cancer |
P35354
(related)
|
H00046 | Cholangiocarcinoma |
P35354
(related)
|
H00088 | Common variable immunodeficiency (CVID) |
P60033
(related)
|
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00612 | Primary open angle glaucoma |
Q16678
(related)
|
H01075 | Peters anomaly |
Q16678
(related)
|
H01159 | Anterior segment dysgenesis (ASD) |
Q16678
(related)
|
H01203 | Primary congenital glaucoma (PCG) |
Q16678
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|